Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30-day readmissions.

Q2 Medicine
World Journal of OtorhinolaryngologyHead and Neck Surgery Pub Date : 2022-05-02 eCollection Date: 2022-06-01 DOI:10.1002/wjo2.56
Sara Yang, William Adams, Carol Bier-Laning
{"title":"Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30-day readmissions.","authors":"Sara Yang, William Adams, Carol Bier-Laning","doi":"10.1002/wjo2.56","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Unplanned 30-day readmissions result in increased costs and decreased patient satisfaction. The objective of this study was to compare readmission rates before and after a multidisciplinary quality improvement initiative that focuses on patient and staff education, use of targeted skilled nursing facilities, and appropriate use of patient observation status.</p><p><strong>Methods: </strong>This was a quality improvement study of all unplanned admissions to the Head and Neck Oncology service at a tertiary care facility during a 3-year period between October 2015 and September 2018. In October 2016, when the Head and Neck Oncology service revised its discharge practices for patients undergoing extirpative and/or reconstructive surgery. These changes included enhancing patient education, increasing the use of a skilled nursing facility with directed staff education and patient handoffs by advanced practice nurses, and appropriate utilization of 23-h observation status for returning patients. The readmission rate from the pre-intervention era (October 2015 through September 2016) was compared to the readmission rate from the post-intervention era (October 2016 through September 2018). Secondary outcomes were the rates of 23-h observation within 30 days of the discharge as well as emergency room visits within 30 days of discharge.</p><p><strong>Results: </strong>In this sample of 449 patients, 161 (35.9%) were observed before the change-in-practice (before October 2016), and 288 (64.1%) were observed following the change-in-practice (after September 2016). On univariable analysis, the risk of readmission declined by approximately 41.4% from the pre-intervention era, though this conclusion was not statistically significant (<i>P</i> = 0.06). On multivariable analysis, patients at moderate or high risk of death were 2.31 times more likely than those at minor risk of death to readmit within 30 days (<i>P</i> = 0.03). Similarly, those with recurrent or persistent cancer were 3.33 times more likely than those undergoing initial curative surgical management of cancer to readmit within 30 days (<i>P</i> = 0.001). No patient characteristics were associated with a 23-h observation following discharge (all <i>P</i> > 0.05). Conclusions were similar for emergency room visits following discharge.</p><p><strong>Conclusions: </strong>A three-part quality improvement strategy resulted in a clinically important decrease in 30-day readmissions, though the decline was not statistically significant. There were no significant changes in 23-h observation within 30 days of discharge or emergency room visits within 30 days of discharge.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"8 2","pages":"158-166"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/66/WJO2-8-158.PMC9242425.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of OtorhinolaryngologyHead and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/wjo2.56","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Unplanned 30-day readmissions result in increased costs and decreased patient satisfaction. The objective of this study was to compare readmission rates before and after a multidisciplinary quality improvement initiative that focuses on patient and staff education, use of targeted skilled nursing facilities, and appropriate use of patient observation status.

Methods: This was a quality improvement study of all unplanned admissions to the Head and Neck Oncology service at a tertiary care facility during a 3-year period between October 2015 and September 2018. In October 2016, when the Head and Neck Oncology service revised its discharge practices for patients undergoing extirpative and/or reconstructive surgery. These changes included enhancing patient education, increasing the use of a skilled nursing facility with directed staff education and patient handoffs by advanced practice nurses, and appropriate utilization of 23-h observation status for returning patients. The readmission rate from the pre-intervention era (October 2015 through September 2016) was compared to the readmission rate from the post-intervention era (October 2016 through September 2018). Secondary outcomes were the rates of 23-h observation within 30 days of the discharge as well as emergency room visits within 30 days of discharge.

Results: In this sample of 449 patients, 161 (35.9%) were observed before the change-in-practice (before October 2016), and 288 (64.1%) were observed following the change-in-practice (after September 2016). On univariable analysis, the risk of readmission declined by approximately 41.4% from the pre-intervention era, though this conclusion was not statistically significant (P = 0.06). On multivariable analysis, patients at moderate or high risk of death were 2.31 times more likely than those at minor risk of death to readmit within 30 days (P = 0.03). Similarly, those with recurrent or persistent cancer were 3.33 times more likely than those undergoing initial curative surgical management of cancer to readmit within 30 days (P = 0.001). No patient characteristics were associated with a 23-h observation following discharge (all P > 0.05). Conclusions were similar for emergency room visits following discharge.

Conclusions: A three-part quality improvement strategy resulted in a clinically important decrease in 30-day readmissions, though the decline was not statistically significant. There were no significant changes in 23-h observation within 30 days of discharge or emergency room visits within 30 days of discharge.

减少头颈部癌症再入院(HANCARRE)项目:减少 30 天再入院率。
目标:计划外 30 天再入院会导致成本增加和患者满意度下降。本研究旨在比较多学科质量改进措施实施前后的再入院率,该措施重点关注患者和员工教育、有针对性地使用专业护理设施以及合理使用患者观察状态:这是一项质量改进研究,研究对象是一家三级医疗机构的头颈部肿瘤科在2015年10月至2018年9月的3年时间里的所有非计划入院患者。2016年10月,头颈部肿瘤学服务部门对接受切除术和/或重建手术患者的出院实践进行了修订。这些改变包括加强患者教育,增加使用专业护理设施,由高级执业护士指导员工教育和患者交接,以及对返院患者适当使用 23 小时观察状态。干预前(2015 年 10 月至 2016 年 9 月)的再入院率与干预后(2016 年 10 月至 2018 年 9 月)的再入院率进行了比较。次要结果是出院后 30 天内的 23 小时观察率以及出院后 30 天内的急诊就诊率:在这449名患者样本中,161人(35.9%)在改变做法之前(2016年10月之前)接受了观察,288人(64.1%)在改变做法之后(2016年9月之后)接受了观察。通过单变量分析,再入院风险比干预前下降了约 41.4%,但这一结论并无统计学意义(P = 0.06)。在多变量分析中,中度或高度死亡风险患者在 30 天内再次入院的可能性是轻度死亡风险患者的 2.31 倍(P = 0.03)。同样,癌症复发或持续存在的患者在 30 天内再次住院的可能性是接受初步治愈性手术治疗的患者的 3.33 倍(P = 0.001)。没有患者特征与出院后 23 小时观察相关(所有 P > 0.05)。出院后急诊就诊的情况也与此类似:由三部分组成的质量改进策略使 30 天再入院率出现了重要的临床下降,尽管下降幅度在统计学上并不显著。出院后 30 天内的 23 小时观察或出院后 30 天内的急诊就诊率没有明显变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
283
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信